Abstract
Background. Sentinel lymph node biopsy (SLNB) is the standard for axillary staging in breast cancer, Techniques for SLN include the use of radioisotope, blue dye, or a combination of both. Sentinel lymph node biopsy with 2 mL of superparamagnetic iron oxide (SPIO) tracer has shown to be non-inferior to the standard radioisotope technique in several studies. The aim of this study is to assess if the efficacy of SLN detection using Sentimag®/SiennaXP®, with different doses of the SPIO is non inferior to the conventional technique (radioisotope).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
